Table 1.
Demographic and clinical data in patients infected with HCV and occult hepatitis B. Rio de Janeiro, 2018
| Categorical variables | N | % |
|---|---|---|
| Gender | ||
| Female | 06 | 54.5 |
| Male | 05 | 45.5 |
| Fibrosis stage | ||
| F2 | 02 | 18.2 |
| F4 | 09 | 81.8 |
| Genotype HCV | ||
| 1a | 05 | 45.5 |
| 1b | 04 | 36.4 |
| 3a | 02 | 18.2 |
| Genotype HBV | ||
| A1 | 01 | 9.1 |
| A2 | 02 | 18.2 |
| ND | 08 | 72.7 |
| Continuos variables | Mean | SD |
|---|---|---|
| Age (years) | 65.64 | 6.89 |
| Viral Load (log) | 3.36 | 1.01 |
| ALT* | 62.91 | 29.92 |
| AST* | 72.09 | 41.95 |
| GGT* | 76.64 | 64.02 |
| BT* | 0.67 | 0.27 |
| Copies/mL—HBV | 1.76E + 07 | 4.56E + 07 |
| IU/mL** | 32,851.90 | 80,988.23 |
| Continuos variables | Median | P25–75 |
|---|---|---|
| Age (years) | 66 | 62–69 |
| Viral Load (log) | 3.26 | 2.61–3.71 |
| ALT* | 68 | 39–76 |
| AST* | 71 | 33–109 |
| GGT* | 65 | 38–94 |
| BT* | 0.80 | 0.40–0.90 |
| Copies/mL—HBV | 1.03E + 04 | 2.26E + 03–8.50E + 04 |
| IU/ml** | 1839.5 | 403–5178.1 |
SD standard deviation, ND not determined, P25 25th percentile, P75 75th percentile
*AST (alanine aminotransferase)—Reference values in chronic hepatitis: < 31 U/L (women) and 37 U/L (men); *ALT (alkaline phosphatase)—Reference values in chronic hepatitis: < 31 U/L (women) and < 41 U/L (men); *GGT (gamma-glutamyl transferase) – Reference values 8–61 U/L (men) and 5–36 U/L (women); *BT (total **1 copies/ml. corresponds to 5.26 IU/ml)